Orphanet: An Open Label, Multicohort, Phase II Study of Atezolizumab in Advanced Solid Tumors Phase 2 AT
x

Search for a clinical trial

* (*) mandatory field

An Open-Label, Multicohort, Phase II Study of Atezolizumab in Advanced Solid Tumors (Phase 2) - AT

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : No
  • Status : Ongoing trial
  • Funding body(ies) :
  • Geographic coverage : Global
  • Sponsor : Hoffmann - la roche ltd.
  • Website
    • Phase : II
  • Principal investigator of clinical trial

  • INFORMATION NOT PROVIDED
  • Institution: Information not provided - AT
  • ADDRESS: NOT PROVIDED - AT
  • AUSTRIA
  • More information
  • Phone  : -
  • Fax  : -
Last update: August 2019

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.